RGEN
REPLIGEN CORP
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$179.95
+0.94%Next report
Analyst consensus
- Next report date
- Feb 23, 2027
- EPS estimate
- $0.53
- Revenue estimate
- $239.8M
Latest reported
- Last report date
- Oct 27, 2026
- EPS actual
- $0.53
- EPS estimate
- $0.46
- Revenue actual
- $209.3M
- Revenue estimate
- $206.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +18.3%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $208
- PT range
- $180 – $225
- Analysts
- 4
3 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 27, 2026 | $0.46 | $0.53 | Beat 14.52% | $209.3M |
| Jul 28, 2026 | $0.45 | $0.54 | Beat 20.81% | $204.1M |
| May 5, 2026 | $0.38 | $0.48 | Beat 26.32% | $194.3M |
| Feb 24, 2026 | $0.44 | $0.49 | Beat 11.36% | $197.9M |
| Oct 28, 2025 | $0.42 | $0.46 | Beat 9.52% | $188.8M |
| Jul 29, 2025 | $0.40 | $0.37 | Miss -7.50% | $182.4M |
| Feb 20, 2025 | $0.41 | $0.44 | Beat 7.32% | $167.5M |
| May 1, 2024 | $0.29 | $0.28 | Miss -3.45% | $151.3M |
| Feb 21, 2024 | $0.34 | $0.33 | Miss -2.94% | $155.7M |
| Oct 31, 2023 | $0.14 | $0.23 | Beat 64.29% | $141.2M |
| Aug 2, 2023 | $0.49 | $0.53 | Beat 8.16% | $159.2M |
| May 2, 2023 | $0.59 | $0.64 | Beat 8.47% | $182.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 23, 2027